Home LiteratureArticle Details
PMID: 2721501 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

The EMBO journal ·Vol. 8 ·No. 3 ·1989-03-00 ·Pages 765-78

Garcia JA, Harrich D, Soultanakis E, Wu F, Mitsuyasu R, Gaynor RB

Abstract

The human immunodeficiency virus (HIV) type 1 LTR is regulated at the transcriptional level by both cellular and viral proteins. Using HeLa cell extracts, multiple regions of the HIV LTR were found to serve as binding sites for cellular proteins. An untranslated region binding protein UBP-1 has been purified and fractions containing this protein bind to both the TAR and TATA regions. To investigate the role of cellular proteins binding to both the TATA and TAR regions and their potential interaction with other HIV DNA binding proteins, oligonucleotide-directed mutagenesis of both these regions was performed followed by DNase I footprinting and transient expression assays. In the TATA region, two direct repeats TC/AAGC/AT/AGCTGC surround the TATA sequence. Mutagenesis of both of these direct repeats or of the TATA sequence interrupted binding over the TATA region on the coding strand, but only a mutation of the TATA sequence affected in vivo assays for tat-activation. In addition to TAR serving as the site of binding of cellular proteins, RNA transcribed from TAR is capable of forming a stable stem-loop structure. To determine the relative importance of DNA binding proteins as compared to secondary structure, oligonucleotide-directed mutations in the TAR region were studied. Local mutations that disrupted either the stem or loop structure were defective in gene expression. However, compensatory mutations which restored base pairing in the stem resulted in complete tat-activation. This indicated a significant role for the stem-loop structure in HIV gene expression. To determine the role of TAR binding proteins, mutations were constructed which extensively changed the primary structure of the TAR region, yet left stem base pairing, stem energy and the loop sequence intact. These mutations resulted in decreased protein binding to TAR DNA and defects in tat-activation, and revealed factor binding specifically to the loop DNA sequence. Further mutagenesis which inverted this stem and loop mutation relative to the HIV LTR mRNA start site resulted in even larger decreases in tat-activation. This suggests that multiple determinants, including protein binding, the loop sequence, and RNA or DNA secondary structure, are important in tat-activation and suggests that tat may interact with cellular proteins binding to DNA to increase HIV gene expression.

MeSH Terms
Base Sequence DNA, Viral/genetics,metabolism DNA-Binding Proteins/metabolism Gene Expression Regulation Genes, Viral HIV-1/genetics,metabolism Humans Molecular Sequence Data Mutation Nucleic Acid Conformation RNA, Viral/genetics,metabolism Repetitive Sequences, Nucleic Acid Transcription, Genetic
Chemicals
DNA, Viral DNA-Binding Proteins RNA, Viral
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Garcia J A
Department of Medicine, UCLA School of Medicine.
Harrich D
Soultanakis E
Wu F
Mitsuyasu R
Gaynor R B
References (49)
49 references, click to expand
  1. Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events.
    Proc Natl Acad Sci U S A. 1987 Sep;84(18):6364-8 PMID: 3476953
  2. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.
    Cell. 1987 Sep 11;50(6):847-61 PMID: 3040262
  3. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.
    J Virol. 1988 Jan;62(1):218-25 PMID: 3257103
  4. Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element.
    Mol Cell Biol. 1987 Oct;7(10):3759-66 PMID: 3500398
  5. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Nature. 1987 Dec 3-9;330(6147):489-93 PMID: 2825027
  6. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
    Science. 1987 Dec 11;238(4833):1575-8 PMID: 2825351
  7. Identification of the human U7 snRNP as one of several factors involved in the 3' end maturation of histone premessenger RNA's.
    Science. 1987 Dec 18;238(4834):1682-7 PMID: 2825355
  8. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.
    EMBO J. 1987 Dec 1;6(12):3761-70 PMID: 3428273
  9. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.
    J Virol. 1988 Mar;62(3):673-9 PMID: 2828663
  10. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells.
    Science. 1988 Mar 11;239(4845):1299-302 PMID: 2830675
  11. Transcriptional but not translational regulation of HIV-1 by the tat gene product.
    Nature. 1988 Apr 7;332(6164):551-3 PMID: 2833703
  12. HIV-1 tat trans-activation requires the loop sequence within tar.
    Nature. 1988 Jul 14;334(6178):165-7 PMID: 3386755
  13. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4700-4 PMID: 3133660
  14. A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator.
    Mol Cell Biol. 1988 Jun;8(6):2555-61 PMID: 2841583
  15. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
    EMBO J. 1988 Jul;7(7):2117-30 PMID: 3138113
  16. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR.
    Science. 1988 Sep 16;241(4872):1481-5 PMID: 3262235
  17. Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat.
    EMBO J. 1988 Oct;7(10):3143-7 PMID: 3181132
  18. Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.
    EMBO J. 1988 Sep;7(9):2831-7 PMID: 3181141
  19. Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID.
    Mol Cell Biol. 1988 Oct;8(10):4028-40 PMID: 3185540
  20. Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters.
    Genes Dev. 1988 Sep;2(9):1101-14 PMID: 2847959
  21. Improved estimation of secondary structure in ribonucleic acids.
    Nat New Biol. 1973 Nov 14;246(150):40-1 PMID: 4519026
  22. DNAse footprinting: a simple method for the detection of protein-DNA binding specificity.
    Nucleic Acids Res. 1978 Sep;5(9):3157-70 PMID: 212715
  23. Organization and expression of eucaryotic split genes coding for proteins.
    Annu Rev Biochem. 1981;50:349-83 PMID: 6791577
  24. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  25. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  26. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
    Science. 1983 May 20;220(4599):868-71 PMID: 6189183
  27. A Drosophila RNA polymerase II transcription factor contains a promoter-region-specific DNA-binding activity.
    Cell. 1984 Feb;36(2):357-69 PMID: 6537904
  28. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
    Science. 1984 May 4;224(4648):500-3 PMID: 6200936
  29. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.
    Science. 1984 Aug 24;225(4664):840-2 PMID: 6206563
  30. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.
    Science. 1985 Jan 11;227(4683):171-3 PMID: 2981427
  31. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
    Cell. 1985 Jul;41(3):813-23 PMID: 2988790
  32. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Jul 5;229(4708):69-73 PMID: 2990040
  33. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
    Science. 1985 Jul 5;229(4708):74-7 PMID: 2990041
  34. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region.
    Cell. 1985 Nov;43(1):165-75 PMID: 4075392
  35. Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.
    Nature. 1986 Feb 13-19;319(6054):555-9 PMID: 3003584
  36. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
    Cell. 1986 Mar 28;44(6):941-7 PMID: 2420471
  37. The trans-activator gene of HTLV-III is essential for virus replication.
    Nature. 1986 Mar 27-Apr 2;320(6060):367-71 PMID: 3007995
  38. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.
    Science. 1986 May 9;232(4751):755-9 PMID: 3008338
  39. A second post-transcriptional trans-activator gene required for HTLV-III replication.
    Nature. 1986 May 22-28;321(6068):412-7 PMID: 3012355
  40. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
    Cell. 1986 Sep 12;46(6):807-17 PMID: 3638988
  41. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.
    Cell. 1986 Sep 26;46(7):973-82 PMID: 3530501
  42. Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system.
    Cell. 1986 Oct 10;47(1):29-35 PMID: 3019564
  43. Expression and characterization of the trans-activator of HTLV-III/LAV virus.
    Science. 1986 Nov 21;234(4779):988-92 PMID: 3490693
  44. Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9734-8 PMID: 3025848
  45. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9759-63 PMID: 2432602
  46. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.
    Cell. 1987 Feb 27;48(4):691-701 PMID: 3643816
  47. An inducible transcription factor activates expression of human immunodeficiency virus in T cells.
    Nature. 1987 Apr 16-22;326(6114):711-3 PMID: 3031512
  48. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.
    Nature. 1987 Jul 9-15;328(6126):175-8 PMID: 2885756
  49. Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.
    Proc Natl Acad Sci U S A. 1987 Oct;84(19):6845-9 PMID: 3498942
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1989-03-00
Pages
765-78
Language
English
Region
England
NLM ID
8208664
PMCID
PMC400873
Subset
IM
Grants
NIAID NIH HHS · AI 25288 · United States
NIGMS NIH HHS · GMO-80942 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com